Total Payments
$439,399
2024 Payments
$6,163
Companies
47
Transactions
1,390
Medicare Patients
140
Medicare Billing
$10,028
Payment Breakdown by Category
Other$291,463 (66.3%)
Travel$81,955 (18.7%)
Consulting$39,059 (8.9%)
Food & Beverage$26,450 (6.0%)
Education$413.78 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $286,463 | 150 | 65.2% |
| Travel and Lodging | $81,955 | 191 | 18.7% |
| Consulting Fee | $39,059 | 23 | 8.9% |
| Food and Beverage | $26,450 | 998 | 6.0% |
| Honoraria | $5,000 | 2 | 1.1% |
| Education | $413.78 | 25 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $98,172 | 213 | $0 (2024) |
| Amarin Pharma Inc. | $68,394 | 237 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $57,046 | 124 | $0 (2022) |
| AbbVie Inc. | $56,907 | 91 | $0 (2023) |
| MannKind Corporation | $46,176 | 120 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $21,183 | 54 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18,308 | 62 | $0 (2024) |
| IBSA Pharma Inc. | $16,273 | 48 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $10,359 | 20 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $7,083 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,163 | 39 | IBSA Pharma Inc. ($5,367) |
| 2023 | $6,282 | 30 | IBSA Pharma Inc. ($5,611) |
| 2022 | $1,352 | 44 | IBSA Pharma Inc. ($558.16) |
| 2021 | $5,544 | 151 | IBSA Pharma Inc. ($1,582) |
| 2020 | $12,567 | 124 | Amarin Pharma Inc. ($5,473) |
| 2019 | $35,441 | 197 | Amarin Pharma Inc. ($16,058) |
| 2018 | $84,248 | 306 | SANOFI-AVENTIS U.S. LLC ($22,349) |
| 2017 | $287,803 | 499 | Lilly USA, LLC ($96,364) |
All Payment Transactions
1,390 individual payment records from CMS Open Payments — Page 3 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2023 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $122.21 | General |
| Category: Endocrinology | ||||||
| 09/28/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $33.02 | General |
| Category: non-opioid analgesic | ||||||
| 07/06/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $6.85 | General |
| Category: non-opioid analgesic | ||||||
| 06/28/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $101.75 | General |
| Category: Bone Health | ||||||
| 06/15/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/24/2023 | IBSA Pharma Inc. | Tirosint (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Endocrinology | ||||||
| 05/24/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $21.22 | General |
| Category: non-opioid analgesic | ||||||
| 05/16/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/26/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $80.50 | General |
| 04/26/2023 | Lilly USA, LLC | LYUMJEV (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Diabetes | ||||||
| 02/16/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $8.86 | General |
| Category: non-opioid analgesic | ||||||
| 02/07/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $82.05 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/02/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiovascular | ||||||
| 01/07/2023 | Lilly USA, LLC | — | Education | In-kind items and services | $0.44 | General |
| 01/06/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: non-opioid analgesic | ||||||
| 09/13/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/08/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $107.66 | General |
| Category: Endocrinology | ||||||
| 09/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 08/29/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Endocrinology | ||||||
| 08/29/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: Endocrinology | ||||||
| 08/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 3 | 140 | 157 | $27,100 | $10,028 |
Total Patients
140
Total Services
157
Medicare Billing
$10,028
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 47 | 53 | $10,600 | $4,659 | 44.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 90 | $14,400 | $4,463 | 31.0% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 14 | 14 | $2,100 | $905.92 | 43.1% |
About Dr. Bruce Trippe, M.D
Dr. Bruce Trippe, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700936200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Trippe, M.D has received a total of $439,399 in payments from pharmaceutical and medical device companies, with $6,163 received in 2024. These payments were reported across 1,390 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($286,463).
As a Medicare-enrolled provider, Trippe has provided services to 140 Medicare beneficiaries, totaling 157 services with total Medicare billing of $10,028. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Dothan, AL
- Active Since 01/10/2007
- Last Updated 04/08/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1700936200
Products in Payments
- TRULICITY (Drug) $78,448
- Vascepa (Drug) $68,394
- AFREZZA (Drug) $46,176
- SOLIQUA (Drug) $39,239
- Synthroid (Drug) $35,346
- JARDIANCE (Drug) $23,337
- INVOKANA (Drug) $21,617
- Androgel (Drug) $21,461
- Tirosint (Drug) $16,200
- TOUJEO (Drug) $11,160
- PRALUENT ALIROCUMAB INJECTION (Biological) $10,282
- FARXIGA (Drug) $6,841
- PRALUENT (Drug) $6,269
- Welchol (Drug) $5,597
- Victoza (Drug) $5,213
- Auryxia (Drug) $3,682
- ZYPITAMAG (pitavastatin) (Drug) $3,012
- NASCOBAL (Drug) $2,371
- Minimed 670G System (Device) $1,736
- Tresiba (Drug) $1,608
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.